Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-27
DOI
10.3389/fimmu.2019.01956
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dengue
- (2019) Annelies Wilder-Smith et al. LANCET
- A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine
- (2019) Iris Valdés et al. JOURNAL OF GENERAL VIROLOGY
- Effective Dengue Vaccines: A Pipe Dream?
- (2019) Lázaro Gil et al. VIRAL IMMUNOLOGY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
- (2018) Kirsten S. Vannice et al. VACCINE
- Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
- (2018) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- The Profile of T Cell Responses in Bacille Calmette–Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine
- (2018) Zhidong Hu et al. Frontiers in Immunology
- A recombinant live attenuated tetravalent vaccine for the prevention of dengue
- (2017) Bruno Guy et al. Expert Review of Vaccines
- Advancing dengue vaccine development
- (2017) Mark B. Feinberg et al. SCIENCE
- Immune correlates of protection for dengue: State of the art and research agenda
- (2017) Leah C. Katzelnick et al. VACCINE
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Bruno Guy Cold Spring Harbor Perspectives in Biology
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Gavin Screaton et al. Cold Spring Harbor Perspectives in Biology
- Progress in HIV vaccine development
- (2017) Denise C. Hsu et al. Human Vaccines & Immunotherapeutics
- New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design
- (2016) Thomas Musich et al. Expert Review of Vaccines
- A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
- (2016) Jorge E. Osorio et al. Expert Review of Vaccines
- A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys
- (2016) Lázaro Gil et al. JOURNAL OF IMMUNOLOGY
- A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response
- (2016) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus–Specific CD4+T-Cell Responses
- (2016) Daniela Weiskopf et al. JOURNAL OF INFECTIOUS DISEASES
- Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians#
- (2016) Emily S. Jentes et al. JOURNAL OF TRAVEL MEDICINE
- Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice
- (2016) Enzhuo Yang et al. MICROBIAL PATHOGENESIS
- Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
- (2016) Sean P. McBurney et al. VACCINE
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
- (2016) Kimia Kardani et al. VACCINE
- Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
- (2016) Philip K. Russell et al. PLoS Neglected Tropical Diseases
- Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
- (2016) Brett M. Forshey et al. PLoS Neglected Tropical Diseases
- Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
- (2015) Iris Valdés et al. ARCHIVES OF VIROLOGY
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- CD8+T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
- (2015) Raphaël M. Zellweger et al. JOURNAL OF VIROLOGY
- VLP production in Leishmania tarentolae : A novel expression system for purification and assembly of HPV16 L1
- (2015) Azam Bolhassani et al. PROTEIN EXPRESSION AND PURIFICATION
- HSP60 – a double edge sword in autoimmunity
- (2015) Dorit Landstein et al. Oncotarget
- Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
- (2014) Edith Suzarte et al. ARCHIVES OF VIROLOGY
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- CD8+T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice
- (2014) Raphaël M. Zellweger et al. JOURNAL OF IMMUNOLOGY
- Valuing vaccination
- (2014) T. Barnighausen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced cell immune responses to hepatitis c virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice
- (2014) Atefeh Saeedi et al. VIRUS GENES
- Complex Correlates of Protection After Vaccination
- (2013) S. A. Plotkin CLINICAL INFECTIOUS DISEASES
- Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
- (2013) Simone C de Cassan et al. Expert Review of Vaccines
- A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
- (2013) Anne Fournillier et al. JOURNAL OF INFECTIOUS DISEASES
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue
- (2013) Adriana S. Azevedo et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Helicobacter pylori -glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance
- (2013) M. Oertli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Prime–boost approaches to tuberculosis vaccine development
- (2012) Neha Dalmia et al. Expert Review of Vaccines
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
- (2011) Iris Valdés et al. Clinical and Vaccine Immunology
- Emerging Vaccine Informatics
- (2011) Yongqun He et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The development of vaccines: how the past led to the future
- (2011) Stanley A. Plotkin et al. NATURE REVIEWS MICROBIOLOGY
- Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2
- (2011) Junu A. George et al. Immune Network
- A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model
- (2010) Gabriela Mellado-Sánchez et al. ARCHIVES OF VIROLOGY
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- DNA Vaccines: Developing New Strategies against Cancer
- (2010) Daniela Fioretti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
- (2010) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic
- (2010) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use
- (2009) Iris Valdés et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of sanofi pasteur tetravalent dengue vaccine
- (2009) Bruno Guy JOURNAL OF CLINICAL VIROLOGY
- A Protective Role for Dengue Virus-Specific CD8+ T Cells
- (2009) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started